FDA Inspection
Xeris Pharmaceuticals, Inc.Xeris Pharmaceuticals, Inc. – FDA Inspection, Mar 14, 2019
Record Details
This FDA Inspection record concerns Xeris Pharmaceuticals, Inc., with an inspection on March 14, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 6369c92b-4d9f-4708-84a3-90f803fa2001
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1086592
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
Other FDA inspections of Xeris Pharmaceuticals, Inc.
2| Date | Classification | Office | Project area |
|---|---|---|---|
| July 3, 2025 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| November 16, 2022 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Xeris Pharmaceuticals, Inc.
- FDA Inspection 1288372 - 2025-07-03
- FDA Inspection 1192023 - 2022-11-16
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.